http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100823799-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
filingDate | 2005-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100823799-B1 |
titleOfInvention | Benzothiazole derivatives |
abstract | The present invention relates to compounds of formula (IA) or (IB), and pharmaceutically acceptable acid addition salts thereof:n n n Formula IAn n n n n n n n Formula IBn n n n n n n n Wheren n n R 1 , R 2 are independently of each other lower alkyl or — (CH 2 ) m —O-lower alkyl, or together with the N atom to which they are attached form a heterocyclic ring;n n n R 3 is hydrogen or lower alkyl;n n n R 4 is lower alkyl;n n n hetaryl is 3H-imidazole-2,4-diyl or 1H-pyrazole-1,4-diyl;n n n n is 1 or 2;n n n m is 1 or 2.n n n The compound may be used in the treatment of drug addictions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, neuroprotection, schizophrenia, anxiety, pain, respiratory deficiency, depression, ADHD, amphetamines, cocaine, opioids, ethanol, nicotine, cannabinoids, or asthma , Allergic reactions, hypoxia, ischemia, seizures and substance abuse, or as a sedative, muscle relaxant, antipsychotic, antiepileptic, anticonvulsant, and coronary artery disease and heart failure. |
priorityDate | 2004-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.